Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.3500
+0.0405 (13.09%)
At close: Aug 10, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $633.57 thousand as of August 11, 2026. Its market cap has decreased by -74.22% in one year.
Market Cap
633.57K
Enterprise Value
2.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
ChartMarket Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 633.57K, a decrease of -93.43%. That is a compound annual growth rate of -89.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 633.57K | -74.81% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agentix | 801.34K |
| Nextel Medical | 790.37K |
| Emmaus Life Sciences | 772.07K |
| SQZ Biotechnologies Company | 707.79K |
| NKGen Biotech | 666.07K |
| Lyra Therapeutics | 603.46K |
| Burzynski Research Institute | 591.52K |
| Halberd | 523.11K |